CD8A and neoplasm: The superior efficacy of hCT3 AbTCR T cells was related to a higher percentage of TSCM and TCM, more robust NFAT signaling, decreased expression of inhibitory immune checkpoint molecules, and increased infiltration of activated CD8+ T cells into the tumor microenvironment.